Abstract: This invention is directed to isolated human AlaGlu-IGF-1, a novel compound which exerts IGF-1 activity and is a valuable precursor in the preparation of IGF-1 itself.
Type:
Grant
Filed:
May 18, 1995
Date of Patent:
January 13, 1998
Assignee:
Novo Nordisk A/S
Inventors:
Lars Skriver, Kim Ry Hejn.ae butted.s, Henrik Dalb.o slashed.ge